Company

Company

Deal value


Foundation Medicine Inc. (Cambridge, Mass.)

Roche AG (Basel, Switzerland)

$1.05B

Depomed Inc. (Newark, Calif.)

Janssen Pharmaceuticals Inc. (New Brunswick, N.J.)

$1.005B

Isis Pharmaceuticals Inc. (Carlsbad, Calif.)

Janssen Biotech Inc. (New Brunswick, N.J.)

$835M

AC Immune SA (Geneva)

Janssen Pharmaceuticals (New Brunswick, N.J.)

$509M

NGM Biopharmaceuticals Inc. (South San Francisco)

Merck & Co. Inc. (Whitehouse Station, N.J.)

$450M

Pfenex Inc. (San Diego)

Hospira Inc. (Lake Forest, Ill.)

$341M

Rigel Pharmaceuticals Inc. (South San Francisco)

Bristol-Myers Squibb Co. (New York)

$339M

Aegerion Pharmaceuticals Inc. (Cambridge, Mass.)

Astrazeneca plc (London)

$325M

Theravance Biopharma Inc. (South San Francisco)

Mylan Inc. (Pittsburgh)

$265M

Vedanta Biosciences Inc. (Boston)

Janssen Biotech Inc. (New Brunswick, N.J.)

$241M